Top

Published in:

01-07-2008 | Gastrointestinal Oncology

Visceral Obesity May Affect Oncologic Outcome in Patients with Colorectal Cancer

Authors: Hyeong-Gon Moon, MD, Young-Tae Ju, MD, Chi-Young Jeong, MD, Eun-Jung Jung, MD, PhD, Young-Joon Lee, MD, PhD, Soon-Chan Hong, MD, PhD, Woo-Song Ha, MD, PhD, Soon-Tae Park, MD, PhD, Sang-Kyung Choi, MD, PhD

Published in: Annals of Surgical Oncology | Issue 7/2008

Abstract

Purpose

Obesity is closely related to the development of colorectal cancer as well as other metabolic complications. We investigated the prognostic significance of visceral obesity and body mass index (BMI) in 161 resectable colorectal cancer patients.

Methods

Ratios of visceral fat area (VFA) to subcutaneous fat area (SFA) were measured from the digital images of patients’ computed tomography taken before the surgery, and patients were divided into those with high and those with low VFA/SFA ratio according to the degree of proportional visceral adiposity, and into an overweight and a normal-weight group according to their preoperative BMI.

Results

The overweight group showed a borderline decrease in cumulative disease-free survival compared to the normal-weight group (P = 0.064). Patients with high VFA/SFA ratio (more than 50 percentiles) had significantly lower cumulative disease-free survival rate compared to patients with low VFA/SFA ratio (P = 0.008). BMI and visceral adiposity showed no influence on overall survival of patients.

Conclusion

Increased visceral adiposity was a significant predictor of disease-free survival in patients with resectable colorectal cancer. The prognostic significance of visceral adiposity should further be determined in a larger set of patients.

Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999–2000. JAMA 2002; 288:1723–7.PubMedCrossRef

Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365:1415–28.PubMedCrossRef

Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4:579–91.PubMedCrossRef

Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol 2002; 3:565–74.PubMedCrossRef

Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348:1625–38.PubMedCrossRef

Schoen RE, Tangen CM, Kuller LH, et al. Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 1999; 91:1147–54.PubMedCrossRef

Murphy TK, Calle EE, Rodriguez C, et al. Body mass index and colon cancer mortality in a large prospective study. Am J Epidemiol 2000; 152:847–54.PubMedCrossRef

IARC. Weight control and physical activityed. Lyon: IARC; Oxford: Oxford University Press [distributor], 2002

Karelis AD, St-Pierre DH, Conus F, et al. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 2004; 89:2569–75.PubMedCrossRef

10.

Otake S, Takeda H, Suzuki Y, et al. Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin Cancer Res 2005; 11:3642–6.PubMedCrossRef

11.

Cowey SL, Quast M, Belalcazar LM, et al. Abdominal obesity, insulin resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression. Cancer 2005; 103:2643–53.PubMedCrossRef

12.

Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol 2002; 20:1128–43.PubMedCrossRef

13.

Berclaz G, Li S, Price KN, et al. Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol 2004; 15:875–84.PubMedCrossRef

14.

Tartter PI, Slater G, Papatestas AE, et al. Cholesterol, weight, height, Quetelet’s index, and colon cancer recurrence. J Surg Oncol 1984; 27:232–5.PubMedCrossRef

15.

Meyerhardt JA, Catalano PJ, Haller DG, et al. Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer 2003; 98:484–95.PubMedCrossRef

16.

Warren M, Schreiner PJ, Terry JG. The relation between visceral fat measurement and torso level–is one level better than another? The Atherosclerosis Risk in Communities Study, 1990–1992. Am J Epidemiol 2006; 163:352.PubMedCrossRef

17.

Giovannucci E, Ascherio A, Rimm EB, et al. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med 1995; 122:327–34.PubMed

18.

Katsuki A, Sumida Y, Urakawa H, et al. Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance. Diabetes Care 2003; 26:2341–4.PubMedCrossRef

19.

Dusserre E, Moulin P, Vidal H. Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues. Biochim Biophys Acta 2000; 1500:88–96.PubMed

Title: Visceral Obesity May Affect Oncologic Outcome in Patients with Colorectal Cancer
Authors: Hyeong-Gon Moon, MD
Young-Tae Ju, MD
Chi-Young Jeong, MD
Eun-Jung Jung, MD, PhD
Young-Joon Lee, MD, PhD
Soon-Chan Hong, MD, PhD
Woo-Song Ha, MD, PhD
Soon-Tae Park, MD, PhD
Sang-Kyung Choi, MD, PhD
Publication date: 01-07-2008
Publisher: Springer-Verlag
Published in: Annals of Surgical Oncology / Issue 7/2008
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-008-9891-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Visceral Obesity May Affect Oncologic Outcome in Patients with Colorectal Cancer

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 7/2008

Multivariate Analysis of the Pathologic Features of Esophageal Squamous Cell Cancer: Tumor Budding Is a Significant Independent Prognostic Factor

The Functional Impact on Voice of Sternothyroid Muscle Division During Thyroidectomy

Intrahepatic Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma: A Western Experience

Beyond the Ivory Tower: Outcomes Following Surgery for Ampullary Cancer

Botulinum Toxin: A Novel Adjuvant for Giant Cell Tumor

Major Hepatectomy for Colorectal Metastases: Is Preoperative Portal Occlusion an Oncological Risk Factor?